LCTX Operating Expenses

Lineage Cell Therapeutics, Inc. Common Stock · Operating Expenses

LCTX logo

LCTX Operating Expenses

Latest reported$39.49M
LCTX TTM Operating Expenses ($700.00K → $39.49M)
High-resolution chart · PNG

LCTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
39,487,000
52,188,000
51,029,000
45,763,000
45,882,000
30,607,000
30,468,000
30,663,000
30,864,000
31,755,000
32,832,000
33,265,000
33,497,000
33,947,000
36,495,000
57,037,000
57,083,000
55,907,000
51,681,000
28,621,000
27,526,000
26,556,000
26,835,000
28,482,000
30,042,000
34,580,000
39,942,000
42,587,000
44,648,000
43,328,000
42,109,000
41,961,000
41,299,000
42,349,000
42,280,000
44,233,000
44,196,000
48,316,000
60,851,000
70,925,000
78,550,000
77,544,000
67,228,471
59,749,294
54,687,505
54,156,580
51,850,014
50,096,828
48,195,523
43,376,933
40,601,335
35,144,842
31,376,311
29,946,903
27,773,082
27,448,305
26,043,349
24,750,819
23,053,849
21,136,431
19,034,000
16,293,155
13,535,888
7,377,437
7,485,783
6,029,821
5,144,570
7,382,375
5,341,825
5,161,984
4,742,076
4,104,691
3,150,732
2,295,372
2,268,612
2,472,899
2,692,560
2,972,396
2,913,879
2,778,096
2,815,742
2,707,815
2,921,611
3,028,523
2,970,729
2,937,562
2,657,151
2,492,400
2,373,254
2,320,144
2,246,250
2,411,798
2,348,046
2,391,975
2,421,649
2,115,341
2,682,406
3,203,690
3,602,601
4,228,931
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.